Archives

by in
Entry Author Date Location
Watch Out SF, Boston Is Turning Into Biotech’s No. 1 Cluster 10/08/12 National
Constant Contact, Bluefin Labs, HP, & More Boston Dealmakers 01/25/12 Boston
Forma Reels In J&J With $700M Deal; 2nd Cancer Drug Discovery Partner in a Week 01/10/12 Boston
Aileron Expands Roche Deal, Agios Gets $78M, Genzyme MS Drug Advances, & More Boston-Area Life Sciences News 11/18/11 Boston
Agios Pharmaceuticals Obtains $78,000,000 Series C Round 11/17/11 Boston
Tolerx Shutters, Courtagen Gets $8M, OvaScience Emerges, & More Boston-Area Life Sciences News 10/14/11 Boston
Courtagen Grabs $8M, Nuance Buys Swype, OpenView Eyes Expansion Stage Investments, & More Boston-Area Deals News 10/12/11 Boston
Celgene Pays Agios $20M, Lycera Adds Cambridge CEO, Getinge Buys Atrium Medical, & More Boston-Area Life Sciences News 10/07/11 Boston
Agios Pulls in $20M From Celgene, Under Extended Cancer Metabolism Partnership 10/05/11 Boston
Genentech Scoops Up Tumor-Starving Drug Program From Forma Therapeutics In Rare Deal 06/27/11 Boston
Forma, After Building Cancer Drug Discovery Engine, Makes First Big Bet on Starving Tumors 03/10/11 Boston
Third Rock Ventures Secures $426M Second Fund, Makes Changes to Partner Ranks 09/13/10 Boston
Biogen Strikes Deal with Knopp for ALS Drugs, Selecta Gets New CEO, Avantra Scores $7M, & More Boston-Area Life Sciences News 08/20/10 Boston
Agios, Nourished with $130M Celgene Deal, Expanding Staff and Labs to Starve Cancer 08/19/10 Boston
Third Rock Ventures, Firm With Hunger for Audacious Biotech Ideas, Sets up SF Shop 08/12/10 San Francisco
Third Rock Invests in Ablexis, Acceleron Grabs $8.4M, Alnylam Chief Joins Agios Board, & More Boston-Area Life Sciences News 06/25/10 Boston
Agios Adds Alnylam Chief to Board 06/24/10 Boston
The Vertex Alumni: Where Are They Now? 04/29/10 Boston
Agios Pharmaceuticals Secures $8,800,000 New Funding 04/26/10 Boston
Oracle Acquires Phase Forward, Diax Collects Up to $12M from Paul Capital, Agios Gets $130M from Celgene, & More Boston-Area Deals News 04/21/10 Boston
Genzyme Activist Joins Board, Agios Clinches Deal With Celgene, Third Rock Seeks $400M New Fund, & More Boston-Area Life Sciences News 04/16/10 Boston
Celgene Pumps $130M Upfront into Agios Pharma for Drugs that Starve Cancer Cells 04/15/10 Boston
Foundation Medicine Raises $25M to Get to the Bottom of Cancer Genomes 04/14/10 Boston
Third Rock Eying $400M Second Fund 04/14/10 Boston
Genetix Pharma Raises $35M from Third Rock, Genzyme for Gene Therapy 03/12/10 Boston
Former CombinatoRx CEO Alexis Borisy Lands at Third Rock Ventures, Launches New Startup 02/11/10 Boston
Biogen Drops Facet Bid, Aveo Reveals IPO Ambitions, Pfizer Partners with Adimab, & More Boston-Area Life Sciences News 12/23/09 Boston
Agios, Seeking to Starve Cancer Cells to Death, Wins Support from Brain Tumor Foundation 12/21/09 Boston
New VC in Boston: Arch Venture Partners Opens Small Office With Eye Toward Basic Science, Multidisciplinary Collaborations 09/21/09 Boston
Genentech Veteran Takes Agios’ Helm, E8 and MIT Take on Navigenics, Genzyme’s Mipomersen Takes Next Step, Alnylam Takes Advantage of Tekmira Technology, & More Boston-Area Life Sciences News 05/28/09 Boston
Page 3 of 4 « previous page · next page »